Claude Nicaise insider trades: Sarepta Therapeutics (SRPT) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Claude reports to the SEC
Open-market buys and sales
1 trade reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Mar 12, 2025 | SRPT | ↓ Sell | 2,491 | $99.64 | $248K | Direct | Mar 13, 2025 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other SRPT insiders
Open-market trades in the last 12 months
About Claude Nicaise's insider trades
Claude Nicaise is an insider at Sarepta Therapeutics (SRPT). Since Mar 12, 2025, Claude has reported no open-market purchases and 1 sale worth $248K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (22 filings), option exercises (2 filings), shares withheld for taxes (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every SRPT insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.